We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Isogenica, Biolauncher and Cresset Biomolecular Discovery Forge Alliance

News   Jun 28, 2011

 
Isogenica, Biolauncher and Cresset Biomolecular Discovery Forge Alliance
 
 
Advertisement
 

RELATED ARTICLES

NIH Announces Clinical Trial To Test Monoclonal Antibodies for COVID-19

News

A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease.

READ MORE

Circulating DNA From Tumor Could Predict Immunotherapy Outcome

News

A newly developed test that detects changing levels of tumor fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immunotherapy, according to researchers.

READ MORE

mRNA-1273 COVID-19 Vaccine Protects Airway in Nonhuman Primate Study

News

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE